Carnitine and Chromium co-supplementation Affects Mental Health, Hormonal, Inflammatory, Genetic and Oxidative Stress Parameters in Women with Polycystic Ovary Syndrome

سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 497

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

LAMOGMED03_051

تاریخ نمایه سازی: 21 بهمن 1397

چکیده مقاله:

Objective: The aim of this study was to evaluate the effect of the co-administration of carnitine and chromium on mental health, hormonal, inflammatory and genetic parameters in women with PCOS.Methods: This randomized, double-blinded, placebo-controlled clinical trial was conducted on 54 subjects, aged 18-40 years old. Subjects were randomly allocated to take either 1,000 mg/day carnitine plus 200 μg/day chromium as chromium picolinate (n=26) or placebo (n=27) for 12 weeks. Gene expression related to inflammation was conducted on peripheral blood mononuclear cells of PCOS women using RT-PCR method.Results: Carnitine and chromium co-supplementation, compared with the placebo, significantly improved beck depression inventory (β -0.84; 95% CI, -1.51, -0.17; P=0.01), general health questionnaire scores (β -1.13; 95% CI, -2.13, -0.14; P=0.02) and depression anxiety and stress scale scores (β -0.96; 95% CI, -0.78, -0.14; P=0.02). Participants who received carnitine plus chromium supplements had significantly lower total testosterone (β -0.15 ng/mL; 95% CI, -0.24, -0.06; P=0.002), hirsutism (β -0.48; 95% CI, -0.91, -0.06; P=0.02), high-sensitivity C-reactive protein (hs-CRP) (β -1.02 mg/L; 95% CI, -1.79, -0.25; P=0.01) and malondialdehyde (MDA) levels (β -0.38 μmol/L; 95% CI, -0.56, -0.20; P<0.001), and higher total antioxidant capacity (TAC) levels (β 107.18 mmol/L; 95% CI, 44.24, 170.12; P=0.001) compared with the placebo. A trend toward a greater increase in sex hormone-binding globulin (P=0.07) was observed among those who took co-supplements compared with the placebo. Moreover, carnitine and chromium co-supplementation upregulated gene expression of interleukin-6 (IL-6) (P=0.02) and tumor necrosis factor alpha (TNF-α) (P=0.02) compared with the placebo.Conclusions: Overall, the co-administration of carnitine and chromium for 12 weeks to women with PCOS had beneficial effects on mental health parameters, serum total testosterone, mF-G scores, hs-CRP, plasma TAC and MDA levels, and gene expression of IL-6 and TNF-α.

نویسندگان

Mehri Jamilian

Endocrinology and Metabolism Research Center, Department of Gynecology and Obstetrics, School of Medicine, Arak University of Medical Sciences, Arak, Iran

Fatemeh Foroozanfard

Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, I.R. Iran

Elham Kavossian

Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, I.R. Iran

Zahra Heidarzadeh

Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran